Abstract
Frailty is a commonly occurring geriatric condition that increases the risk of adverse health outcomes. The factors and predictors behind frailty are not yet well understood. A better understanding of these factors can enable prevention of frailty in elderly patients. The objective of this study was to determine the association between proteinuria and frailty in US individuals with metabolic syndrome (MetS). Data from the National Health and Nutrition Examination Survey III (NHANES III, 1988–1994) conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. This is a cross-sectional study, and proteinuria and frailty were measured only once at enrollment. The study included 2,272 participants with MetS aged 40–90 years from the NHANES III. The participants underwent assessments to evaluate frailty and frailty components (low body weight, weakness, exhaustion, low physical activity, and slow walking). Proteinuria was represented as albumin-to-creatinine ratio (ACR) (mg/g) and divided into tertiles: T1-normal range (ACR <30 mg/g), T2-microalbuminuria (ACR 30–299 mg/g), and T3-macroalbuminuria (ACR ≥ 300 mg/g). We applied multiple logistic regression to determine the odds ratios (ORs) of frailty for T2 vs. T1 and T3 vs. T1 in both sexes. In the adjusted analysis for male participants, the ORs of frailty for T2 and T3 vs. T1 were 3.106 (95% confidence interval [CI] = 1.078–8.948, P = 0.036) and 14.428 (95% CI = 4.231–49.193, P < 0.001), respectively. For female participants, the ORs of frailty for T2 and T3 vs. T1 were 1.811 (95% CI = 1.071–3.063, P = 0.027) and 2.926 (95% CI = 1.202–7.124, P = 0.018), respectively. The positive association between T2 and T3 vs. T1, and frailty were statistically significant. The trends of higher likelihood of every frailty component were also statistically significant across increasing tertiles of proteinuria after multiple levels of adjustment for covariates (P < 0.05). Increased proteinuria levels were positively associated with frailty and each frailty component. Proteinuria might be a useful maker for frailty in individuals with MetS.
Highlights
Metabolic syndrome (MetS) is defined as a collection of cardiovascular risk factors, including elevated levels of triglycerides, low concentrations of high-density lipoprotein cholesterol, impaired fasting glucose, central obesity, and elevated blood pressure [1]
A previous study suggested that frailty is associated with chronic kidney diseases (CKDs), and albuminuria is an early indicator of diabetic nephropathy [4– 6]
CKDs have been extensively documented as a crucial factor in frailty, data examining the associations of early indicators of CKDs, such as albuminuria, with frailty are relatively sparse
Summary
Metabolic syndrome (MetS) is defined as a collection of cardiovascular risk factors, including elevated levels of triglycerides, low concentrations of high-density lipoprotein cholesterol, impaired fasting glucose, central obesity, and elevated blood pressure [1]. The prevalence rate of MetS is high and is increasing worldwide [2]. MetS is a risk factor for developing diabetes and cardiovascular disease and raises the possibility of all-cause and cardiovascular mortality in aging individuals [3]. Older adults are at an increased risk of adverse health outcomes such as institutionalization, comorbidity, and mortality. Developing a better understanding of indicators that can be used to identify high-risk individuals is a major step toward preventing frailty. A previous study suggested that frailty is associated with chronic kidney diseases (CKDs), and albuminuria is an early indicator of diabetic nephropathy [4– 6]. CKDs have been extensively documented as a crucial factor in frailty, data examining the associations of early indicators of CKDs, such as albuminuria, with frailty are relatively sparse. Albuminuria is associated with frailty among community-dwelling middle-aged and older people [7]. Representative samples were retrieved from the U.S National Health and Nutrition Examination Survey III (NHANES III, 1988–1994)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.